| Literature DB >> 27005636 |
Mary L Hamilton1, Stephen Powers2, Johnathan A Napier3, Olga Sayanova4.
Abstract
We have created via metabolic engineering a heterotrophic strain of Phaeodactylum tricornutum that accumulates enhanced levels of the high value omega-3 long chain polyunsaturated fatty acid (LC-PUFAs) docosahexaenoic acid (DHA). This was achieved by generation of transgenic strains in which the Δ5-elongase from Ostreococcus tauri was co-expressed with a glucose transporter from the moss Physcomitrella patens. This double transformant has the capacity to grow in the dark in liquid medium supplemented with glucose and accumulate substantial levels of omega-3 LC-PUFAs. The effects of glucose concentrations on growth and LC-PUFA production of wild type and transformed strains cultivated in the light and dark were studied. The highest omega-3 LC-PUFAs accumulation was observed in cultures grown under mixotrophic conditions in the presence of 1% glucose (up to 32.2% of total fatty acids, TFA). Both DHA and EPA are detected at high levels in the neutral lipids of transgenic cells grown under phototrophic conditions, averaging 36.5% and 23.6% of TFA, respectively. This study demonstrates the potential for P. tricornutum to be developed as a viable commercial strain for both EPA and DHA production under mixo- and heterotrophic conditions.Entities:
Keywords: DHA; EPA; Phaeodactylum tricornutum; heterotrophic; microalgae; omega-3 long chain polyunsaturated fatty acid
Mesh:
Substances:
Year: 2016 PMID: 27005636 PMCID: PMC4820307 DOI: 10.3390/md14030053
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Fatty acids composition of wild type (WT) and transgenic Pt_Elo5, Pt_HElo5_5 and Pt_HElo5_7 cells grown in the presence of 1% glucose in the light (+L) or in the dark (−L). Values are the average of three biological replicates (±standard error).
| 14:0 | 16:0 | 16:1 | 16:3 | 18:0 | 18:1 | 18:2 | EPA | DPA | DHA | Others | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WT + L | 5.2 ± 0.1 | 14.6 ± 0.2 | 38.5 ± 1.4 | 2.7 ± 0.1 | 0.4 ± 0.1 | 7.4 ± 1.1 | 0.3 ± 0.2 | 24.7 ± 0.6 | nd | 1.8 ± 0.1 | 2.7 ± 0.1 |
| Pt_Elo5 + L | 5.1 ± 0.2 | 14.1 ± 0.5 | 35.1 ± 1.2 | 7.7 ± 0.3 | 1.5 ± 0.1 | 2.5 ± 0.1 | 0.7 ± 0.1 | 15.9 ± 0.5 | 1.9 ± 0.3 | 6.3 ± 0.1 | 11.6 ± 1.7 |
| Pt_HElo5_5 + L | 5.7 ± 1.0 | 15.6 ± 0.4 | 32.6 ± 0.6 | 6.3 ± 0.8 | 0.3 ± 0.1 | 2.8 ± 0.5 | 1.0 ± 0.1 | 19.0 ± 1.2 | 3.3 ± 0.2 | 7.5 ± 0.3 | 5.1 ± 0.4 |
| Pt_HElo5_5 − L | 7.1 ± 0.9 | 23.4 ± 1.3 | 22.4 ± 3.8 | 8.2 ± 1.8 | 2.0 ± 0.7 | 11.7 ± 2.9 | 6.3 ± 1.8 | 19.9 ± 2.6 | 5.2 ± 0.6 | 7.3 ± 1.8 | 14.2 ± 2.3 |
| Pt_HElo5_7 + L | 6.1 ± 0.5 | 11.8 ± 0.7 | 34.5 ± 3.1 | 7.0 ± 0.5 | 1.4 ± 0.2 | 1.8 ± 0.3 | 0.7 ± 0.1 | 11.9 ± 0.7 | 1.8 ± 1.1 | 8.1 ± 0.7 | 7.9 ± 0.4 |
| Pt_HElo5_7 − L | 9.5 ± 0.6 | 22.1 ± 0.2 | 13.8 ± 0.1 | 7.1 ± 0.1 | 1.0 ± 0.1 | 7.7 ± 0.1 | 1.4 ± 0.1 | 13.9 ± 0.1 | 9.1 ± 2.3 | 5.2 ± 0.3 | 5.7 ± 0.2 |
| F-test ( | 0.217 | 0.002 | 0.045 | <0.001 | <0.001 | <0.001 | 0.159 | <0.001 | <0.001 | <0.001 | <0.001 |
| SED | - * | 0.70 | 2.58 | 0.40 | 0.20 | 0.79 | - | 0.72 | 0.18 | 0.81 | 0.19 |
| df | - | 8 | 8 | 8 | 8 | 8 | - | 8 | 6 | 8 | 8 |
| LSD (5%) | - | 1.60 | 5.96 | 0.91 | 0.40 | 1.83 | - | 1.65 | 0.44 | 1.87 | 0.43 |
* No significant (p < 0.05, F-test) difference between treatments, so no SED required for comparisons of means.
Figure 1Cellular growth of transgenic cells. (a) in the light (p = 0.491, SED = 0.551 on 4df, t-test); (b) in the light plus glucose (p = 0.080, SED = 1.319 on 4df, t-test); (c) in the dark plus glucose (p < 0.001, SED = 0.683 on 6df, LSD (5%) = 1.672, ANOVA: 1% and 5% glucose significantly different from 2%, and p < 0.05, LSD. No significant differences between 1% and 5%). Values are the average of three biological replicates (±standard error).
Figure 2Fatty acid composition of transgenic Pt_HElo5_5 cells grown under different glucose concentrations in the dark and in the light. % indicates glucose concentration; +L, dark grown cells transferred to light conditions for 24 h; CL, cells grown under constant light. Values are the average of three biological replicates (±standard error). For quantitative statistical analysis, see Supplementary Table S1.
Accumulation of EPA, DPA and DHA in transgenic cells grown in the light (L); in the light plus glucose (L + G); in the dark plus glucose (−L + G). Values are the average of three biological replicates (±standard error).
| Cells | LC-PUFA μg/mg Dry Weight | ||
|---|---|---|---|
| EPA | DPA | DHA | |
| Pt_Elo5/L | 6.0 ± 0.8 | 1.5 ± 0.1 | 3.6 ± 0.8 |
| Pt_HElo5_5/L | 6.0 ± 1.0 | 1.1 ± 0.3 | 2.5 ± 0.3 |
| Pt_Elo5/L + 1% G | 4.7 ± 0.2 | 1.1 ± 0.1 | 2.8 ± 0.2 |
| Pt_HElo5_5/L + 1% G | 8.0 ± 0.5 | 1.4 ± 0.1 | 3.1 ± 0.2 |
| Pt_HElo5_5/−L + 1% G | 3.4 ± 0.2 | 1.3 ± 0.3 | 1.0 ± 0.1 |
| Pt_HElo5_5/−L + 2% G | 3.6 ± 0.1 | 1.7 ± 0.1 | 1.0 ± 0.1 |
| Pt_HElo5_5/−L + 5% G | 3.3 ± 0.4 | 1.3 ± 0.2 | 1.0 ± 0.1 |
| <0.001 | 0.302 | <0.001 | |
| SED | 0.76 | - * | 0.47 |
| df | 14 | - | 14 |
| LSD (5%) | 1.63 | - | 1.00 |
* No significant (p < 0.05, F-test) difference between treatments, so no SED required for comparisons of means.
Lipid analyses of transgenic cells grown in the light (L); in the light plus glucose (L + G); in the dark plus 1% glucose (−L + G). Values are the average of three biological replicates (±standard error). For quantitative statistical analysis, see Supplementary Table S2.
| Strain | NL | GL | PL | ||||||
|---|---|---|---|---|---|---|---|---|---|
| EPA | DPA | DHA | EPA | DPA | DHA | EPA | DPA | DHA | |
| Pt_Elo5/L | 23.8 ± 7.4 | 16.2 ± 7.7 | 12.9 ± 3.0 | 58.9 ± 6.4 | 7.7 ± 4.2 | 8.5 ± 2.5 | 17.3 ± 4.0 | 76.1 ± 12.3 | 78.6 ± 17.1 |
| Pt_HElo5_5/ L | 36.5 ± 4.8 | 32.9 ± 4.6 | 23.6 ± 1.7 | 48.1 ± 9.6 | 12.8 ± 2.3 | 13.9 ± 1.3 | 15.4 ± 4.5 | 54.3 ± 24.6 | 62.5 ± 6.9 |
| Pt_Elo5/ L + G | 20.2 ± 2.3 | 14.5 ± 2.3 | 11.9 ± 2.3 | 63.9 ± 12.0 | 5.9 ± 0.9 | 6.7 ± 1.4 | 15.9 ± 1.6 | 79.5 ± 8.3 | 81.4 ± 13.5 |
| Pt_HElo5_5/L + G | 18.7 ± 0.8 | 17.3 ± 0.7 | 12.5 ± 0.1 | 56.1 ± 2.1 | 6.5 ± 0.2 | 7.1 ± 0.2 | 25.2 ± 1.0 | 76.1 ± 4.0 | 80.4 ± 2.3 |
| Pt_HElo5_5/−L + G | 19.1 ± 2.5 | 16.1 ± 2.2 | 10.9 ± 0.8 | 56.8 ± 0.1 | 11.8 ± 1.6 | 14.9 ± 3.8 | 24.1 ± 5.9 | 72.2 ± 5.9 | 74.1 ± 16.6 |